
Latest fund size
$450M
Announced
December 1, 2024
Global HQ
United States
Members only
Check size
$5M - $25M
Members only
Stage focus
Seed, Series A
Members only
Regions of investment
North America, Europe
Members only
Atlas Venture is an early-stage venture capital firm specializing in the creation and investment in biotechnology startups. Headquartered in Cambridge, Massachusetts, Atlas has been instrumental in building breakthrough biotech companies for over 30 years.
Members only
Names, roles, emails and LinkedIn profiles for the team, plus the fund's website.
Atlas Venture employs a seed-led venture creation strategy, partnering with exceptional entrepreneurs and scientists to translate groundbreaking science into life-changing medicines. The firm focuses on building scalable businesses across various disease areas, modalities, and business models, maintaining a disciplined approach to its portfolio.
Members only
What the fund looks for in founders and which sectors it backs.
In December 2024, Atlas Venture announced the closing of its fourteenth fund, raising $450 million to invest in early-stage biotech startups. This fund continues the firm's commitment to collaborating with talented entrepreneurs to found, seed, incubate, and invest in new biotech companies aimed at bringing novel therapeutics to patients.
Members only
Fund size, LPs and track record.
Team
The Atlas Venture team comprises experienced professionals dedicated to translating high-impact science into medicines for patients. Key members include:
Notable Investments and Exits
Atlas Venture has a history of successful investments and exits, including:
Members only
Leadership, investment strategy, notable investments and exits.